CAMP4 Therapeutics Corp. (CAMP)
4.31
-0.25
(-5.48%)
USD |
NASDAQ |
Mar 27, 16:00
4.38
+0.07
(+1.62%)
After-Hours: 20:00
CAMP4 Therapeutics EPS Diluted (Quarterly) : -0.7762 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | -1.080 |
| Tyra Biosciences, Inc. | -0.5655 |
| Entrada Therapeutics, Inc. | -0.9414 |
| Praxis Precision Medicines, Inc. | -3.500 |
| Vor Biopharma, Inc. | -121.63 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.28M |
| Revenue (Quarterly) | 0.348M |
| Total Expenses (Quarterly) | 40.63M |
| Enterprise Value | 114.88M |
| Gross Profit Margin (Quarterly) | -6.90% |
| Profit Margin (Quarterly) | -11.58K% |
| Earnings Yield | -59.65% |
| Normalized Earnings Yield | -49.52 |